Internship
Stryker
10,001+ employees
Develops and manufactures medical devices and equipment
No salary listed
No H1B Sponsorship
Fort Lauderdale, FL, USA
Upload your resume to see how it matches 8 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
- Currently working on completion of a Bachelor’s or Master’s degree in related field or equivalent; we will only consider students who plan to be enrolled in a degree-seeking program after the summer.
- Cumulative 3.0 GPA or above; must be the case at the date of hire and will be verified during background check in the spring.
- Must be legally authorized to work in the U.S. and not require employment-based sponsorship now or in the future.
- Excellent written and verbal communication skills.
- Strong interpersonal skills.
- Ability to exercise independent judgment and proven leadership and business acumen skills.
- Proven ability to handle multiple projects and meet deadlines.
- Versatility, flexibility, and a willingness to work within constantly changing priorities with enthusiasm.
- Strong organizational, problem-solving, and analytical skills; able to manage priorities and workflow.
- Proficient on basic computer programs: Microsoft Excel, Word, PowerPoint.
- Apply classroom knowledge and gain experience in a fast-paced and growing industry setting.
- Implement new ideas, be constantly challenged, and develop your skills.
- Network with key/high-level stakeholders and leaders of the business.
- Be a part of an innovative team and culture.
- Impact the development and manufacturing of cutting-edge products.
Stryker develops and manufactures medical devices and equipment aimed at improving patient care and surgical efficiency. Their products include surgical tools, neurotechnology devices, and orthopedic implants, which are sold directly to hospitals and clinics worldwide. Stryker stands out from competitors by focusing on high-quality products and a commitment to advancing healthcare solutions. The company's goal is to enhance the overall healthcare experience for both patients and medical professionals.
Company Size
10,001+
Company Stage
IPO
Headquarters
Kalamazoo, Michigan
Founded
1941
Simplify's Take
What believers are saying
- Growing demand for minimally invasive solutions aligns with Stryker's strategic acquisitions.
- The orthopedic implants market growth benefits Stryker's expanding product line.
- Stryker's acquisition of Inari Medical positions it in a high-growth vascular market.
What critics are saying
- Integration challenges from acquisitions may strain Stryker's resources.
- Rapid tech advancements risk obsolescence of Stryker's current products.
- Regulatory scrutiny on acquisitions could delay Stryker's market entry.
What makes Stryker unique
- Stryker's acquisitions enhance its minimally invasive surgical solutions portfolio.
- Entry into the peripheral vascular segment diversifies Stryker's market presence.
- Stryker's focus on AI integration boosts diagnostic accuracy and operational efficiency.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Medical & prescription plans
Supplemental health benefits
Flexible Spending accounts
Employee Assistance Program
Short-term & long-term disability
Tuition reimbursement
401(k) plan
Employee Stock Purchase Plan
Company News
Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced...
/PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of NICO Corporation, a...
Stryker has announced a definitive agreement to acquire Vertos Medical, a privately held company providing a minimally invasive solution.
Stryker has announced a definitive agreement to acquire care.ai.
Stryker (NYSE:SYK) has completed the acquisition of MOLLI Surgical Inc., a company specializing in wire-free soft tissue localization technology for breast conserving surgery. The MOLLI 2 localization system enhances surgical workflow with its small 3.2 mm marker and real-time feedback. This acquisition strengthens Stryker's breast cancer care portfolio, complementing its existing SPY fluorescence imaging technology. For more information, visit www.stryker.com.